140 related articles for article (PubMed ID: 27611948)
21. Alterations in ZnT1 expression and function lead to impaired intracellular zinc homeostasis in cancer.
Lehvy AI; Horev G; Golan Y; Glaser F; Shammai Y; Assaraf YG
Cell Death Discov; 2019; 5():144. PubMed ID: 31728210
[TBL] [Abstract][Full Text] [Related]
22. Xenobiotic metabolism and disposition in human lung: transcript profiling in non-tumoral and tumoral tissues.
Leclerc J; Courcot-Ngoubo Ngangue E; Cauffiez C; Allorge D; Pottier N; Lafitte JJ; Debaert M; Jaillard S; Broly F; Lo-Guidice JM
Biochimie; 2011 Jun; 93(6):1012-27. PubMed ID: 21376776
[TBL] [Abstract][Full Text] [Related]
23. The clinical significance of FSCN1 in non-small cell lung cancer.
Luo A; Yin Y; Li X; Xu H; Mei Q; Feng D
Biomed Pharmacother; 2015 Jul; 73():75-9. PubMed ID: 26211585
[TBL] [Abstract][Full Text] [Related]
24. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
[TBL] [Abstract][Full Text] [Related]
25. [Investigation of the importance of zinc-signaling: insights from animal model study and human disease].
Takagishi T; Hara T; Fukada T
Nihon Yakurigaku Zasshi; 2019; 154(6):327-334. PubMed ID: 31787685
[TBL] [Abstract][Full Text] [Related]
26. [Expression of TR4-associated protein in non-small cell lung cancer].
Zheng QF; Dong B; Sun Y; DU H; Xiong HC; Wu N; Chen JF; Sun L; Ao J; Li JY; Ji JF; Yang Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Oct; 39(5):472-5. PubMed ID: 17940562
[TBL] [Abstract][Full Text] [Related]
27. In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancers.
Washimi O; Nagatake M; Osada H; Ueda R; Koshikawa T; Seki T; Takahashi T; Takahashi T
Cancer Res; 1995 Feb; 55(3):514-7. PubMed ID: 7834619
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
[TBL] [Abstract][Full Text] [Related]
29. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
[TBL] [Abstract][Full Text] [Related]
30. Increased serum and urinary levels of a parathyroid hormone-related protein COOH terminus in non-small cell lung cancer patients.
Nishigaki Y; Ohsaki Y; Toyoshima E; Kikuchi K
Clin Cancer Res; 1999 Jun; 5(6):1473-81. PubMed ID: 10389935
[TBL] [Abstract][Full Text] [Related]
31. Dishevelled family proteins are expressed in non-small cell lung cancer and function differentially on tumor progression.
Wei Q; Zhao Y; Yang ZQ; Dong QZ; Dong XJ; Han Y; Zhao C; Wang EH
Lung Cancer; 2008 Nov; 62(2):181-92. PubMed ID: 18692936
[TBL] [Abstract][Full Text] [Related]
32. Multidrug resistance-associated protein (MRP) gene expression in human lung cancer.
Narasaki F; Matsuo I; Ikuno N; Fukuda M; Soda H; Oka M
Anticancer Res; 1996; 16(4A):2079-82. PubMed ID: 8712746
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-663a is downregulated in non-small cell lung cancer and inhibits proliferation and invasion by targeting JunD.
Zhang Y; Xu X; Zhang M; Wang X; Bai X; Li H; Kan L; Zhou Y; Niu H; He P
BMC Cancer; 2016 May; 16():315. PubMed ID: 27184257
[TBL] [Abstract][Full Text] [Related]
34. Protein expression in human non-small cell lung cancer: a systematic database.
Bührens RI; Amelung JT; Reymond MA; Beshay M
Pathobiology; 2009; 76(6):277-85. PubMed ID: 19955839
[TBL] [Abstract][Full Text] [Related]
35. YB-1 promotes transcription of cyclin D1 in human non-small-cell lung cancers.
Harada M; Kotake Y; Ohhata T; Kitagawa K; Niida H; Matsuura S; Funai K; Sugimura H; Suda T; Kitagawa M
Genes Cells; 2014 Jun; 19(6):504-16. PubMed ID: 24774443
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-661 promotes non-small cell lung cancer progression by directly targeting RUNX3.
Wang Y; Li Y; Wu B; Shi C; Li C
Mol Med Rep; 2017 Aug; 16(2):2113-2120. PubMed ID: 28656235
[TBL] [Abstract][Full Text] [Related]
37. Human RNA polymerase II associated factor 1 complex promotes tumorigenesis by activating c-MYC transcription in non-small cell lung cancer.
Zhi X; Giroux-Leprieur E; Wislez M; Hu M; Zhang Y; Shi H; Du K; Wang L
Biochem Biophys Res Commun; 2015 Oct; 465(4):685-90. PubMed ID: 26282204
[TBL] [Abstract][Full Text] [Related]
38. Role of RLIP76 in lung cancer doxorubicin resistance: II. Doxorubicin transport in lung cancer by RLIP76.
Awasthi S; Singhal SS; Singhal J; Cheng J; Zimniak P; Awasthi YC
Int J Oncol; 2003 Apr; 22(4):713-20. PubMed ID: 12632060
[TBL] [Abstract][Full Text] [Related]
39. Comparative proteome analysis across non-small cell lung cancer cell lines.
Grundner-Culemann K; Dybowski JN; Klammer M; Tebbe A; Schaab C; Daub H
J Proteomics; 2016 Jan; 130():1-10. PubMed ID: 26361996
[TBL] [Abstract][Full Text] [Related]
40. PPARGC1A is upregulated and facilitates lung cancer metastasis.
Li JD; Feng QC; Qi Y; Cui G; Zhao S
Exp Cell Res; 2017 Oct; 359(2):356-360. PubMed ID: 28803067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
